Search
Menu
Home
HTB
2002
September
September 2002
Contents
On the web
‘Natural’ resistance to HIV: is the evidence good enough to design an effective vaccine?
Insights into HIV-specific CD4+ T cell immunity
Cytomegalovirus: update
The switching spiral: a triumph of hope over benefit?
Peripheral neuropathy
The push for once-daily HAART: a call for caution
Enhancing adherence to antiretrovirals: strategies and regimens
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia
HAART and prevention of HIV transmission
PDFs
Volume 3 Number 7 August/September 2002 PDF
Post navigation
Newer articles
HTB RSS
Early access
CROI 2025: Introduction to this year’s conference
9 March 2025
CROI 2025: Stand up for science rally against Trump funding freeze
9 March 2025
CROI 2025: Jay Bhattacharya is proposed to head the US NIH which would further wreck global science
7 March 2025
All early access reports
Current issues
March 2025
February 2025
January 2025
Back issues
Special report
Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer
1 March 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate